172 related articles for article (PubMed ID: 15144579)
1. Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector.
Ho IA; Hui KM; Lam PY
Hum Gene Ther; 2004 May; 15(5):495-508. PubMed ID: 15144579
[TBL] [Abstract][Full Text] [Related]
2. Engineering an improved cell cycle-regulatable herpes simplex virus type 1 amplicon vector with enhanced transgene expression in proliferating cells yet attenuated activities in resting cells.
Wang GY; Ho IA; Sia KC; Miao L; Hui KM; Lam PY
Hum Gene Ther; 2007 Mar; 18(3):222-31. PubMed ID: 17355186
[TBL] [Abstract][Full Text] [Related]
3. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
4. Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin.
Suzuki M; Kasai K; Saeki Y
J Virol; 2006 Apr; 80(7):3293-300. PubMed ID: 16537596
[TBL] [Abstract][Full Text] [Related]
5. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.
Lam PY; Sia KC; Khong JH; De Geest B; Lim KS; Ho IA; Wang GY; Miao LV; Huynh H; Hui KM
Mol Ther; 2007 Jun; 15(6):1129-36. PubMed ID: 17426711
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
7. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration.
Wang Y; Camp SM; Niwano M; Shen X; Bakowska JC; Breakefield XO; Allen PD
J Virol; 2002 Jul; 76(14):7150-62. PubMed ID: 12072515
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
10. The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy.
Miao L; Fraefel C; Sia KC; Newman JP; Mohamed-Bashir SA; Ng WH; Lam PY
Br J Cancer; 2014 Jan; 110(1):94-106. PubMed ID: 24196790
[TBL] [Abstract][Full Text] [Related]
11. Targeting proliferating tumor cells via the transcriptional control of therapeutic genes.
Ho IA; Hui KM; Lam PY
Cancer Gene Ther; 2006 Jan; 13(1):44-52. PubMed ID: 16037822
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
[TBL] [Abstract][Full Text] [Related]
13. Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/adeno-associated virus hybrid amplicon vector.
Liu Q; Perez CF; Wang Y
J Virol; 2006 Feb; 80(4):1672-9. PubMed ID: 16439524
[TBL] [Abstract][Full Text] [Related]
14. Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector.
Kummer C; Winkeler A; Dittmar C; Bauer B; Rueger MA; Rueckriem B; Heneka MT; Vollmar S; Wienhard K; Fraefel C; Heiss WD; Jacobs AH
Mol Imaging; 2007; 6(3):181-92. PubMed ID: 17532884
[TBL] [Abstract][Full Text] [Related]
15. Targeting human glioma cells using HSV-1 amplicon peptide display vector.
Ho IA; Miao L; Sia KC; Wang GY; Hui KM; Lam PY
Gene Ther; 2010 Feb; 17(2):250-60. PubMed ID: 19812609
[TBL] [Abstract][Full Text] [Related]
16. Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cells.
Sia KC; Chong WK; Ho IA; Yulyana Y; Endaya B; Huynh H; Lam PY
J Gene Med; 2010 Oct; 12(10):848-58. PubMed ID: 20963807
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression.
Lu B; Federoff HJ
Hum Gene Ther; 1995 Apr; 6(4):419-28. PubMed ID: 7612699
[TBL] [Abstract][Full Text] [Related]
18. Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors.
Shering AF; Bain D; Stewart K; Epstein AL; Castro MG; Wilkinson GW; Lowenstein PR
J Gen Virol; 1997 Feb; 78 ( Pt 2)():445-59. PubMed ID: 9018068
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplicon vectors.
Lam P; Hui KM; Wang Y; Allen PD; Louis DN; Yuan CJ; Breakefield XO
Hum Gene Ther; 2002 Dec; 13(18):2147-59. PubMed ID: 12542846
[TBL] [Abstract][Full Text] [Related]
20. Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.
Han F; Miyagawa Y; Verlengia G; Ingusci S; Soukupova M; Simonato M; Glorioso JC; Cohen JB
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
